Sentences with phrase «with early stage cancer»

Scenario 2: Mr. Bajaj was diagnosed with Early stage cancer in 8th Policy year.

Unfortunately, he was diagnosed with an Early Stage Cancer and after few years with Major Stage Cancer, within the Policy term.

Premiums are waived for the entire policy term in case the insured is diagnosed with early stage cancer.

When his team looked at gene expression changes in the mice, then applied them to humans with early stage cancer, the results revealed a breakdown of which patients have a high or low chance of survival.

Moreover, analysis of HAND2 methylation in endometrial secretions collected from women with postmenopausal bleeding (which can be a symptom of endometrial cancer) accurately identified individuals with early stage cancer.

Not exact matches

Intuitive has teamed up with China's Fosun Pharma, for instance, in a joint venture to detect lung cancers in their earliest stages, developing a flexible robotic catheter that can navigate into the cavernous regions of the lungs.

He had stepped down as Northern Ireland secretary in January because of ill health after being diagnosed with the early stages of lung cancer.

Time Business 3 pm Oral Questions Designation of sites as Marine Conservation Areas - Lord Eden of Winton Consultation of early years practitioners on their plans to increase the maximum ratio of carers to babies and toddlers - Earl of Listowel Replacing the Cancer Drugs Fund with a new scheme - Lord Hunt of Kings Heath Legislation Succession to the Crown Bill - Report stage - Lord Wallace of Tankerness Legislation Groceries Code Adjudicator Bill [HL]- Consideration of Commons amendments - Baroness Wilcox Short Debate Impact of discrimination against gay men and women in Commonwealth countries on efforts to halt the spread of HIV / AIDS - Lord Black of Brentwood

Dr Catherine Pickworth from Cancer Research UK, said: «This early stage study adds to the growing evidence that some men with prostate cancer could benefit from being given PARP inhibitors alongside hormone deprivation treaCancer Research UK, said: «This early stage study adds to the growing evidence that some men with prostate cancer could benefit from being given PARP inhibitors alongside hormone deprivation treacancer could benefit from being given PARP inhibitors alongside hormone deprivation treatment.

«An estimated 220,000 men are expected to be newly diagnosed with prostate cancer each year in the United States, and the majority will have early - stage disease at low risk for recurrence,» Lee said.

«Patients diagnosed with early - stage prostate cancer — and that's the vast majority of patients with this disease — face many treatment options that are thought to be similarly efficacious,» said Ronald C. Chen, MD, MPH, UNC Lineberger member and associate professor in the UNC School of Medicine Department of Radiation Oncology.

During the design process, she consulted with dermatologists, who suggested the device might also identify some skin cancers in their earliest stages.

Prostate cancer is highly curable, with a 94 percent 15 - year relative survival rate for early stages.

For patients with early - stage cancer, this option avoids many of the side effects associated with removing the prostate or irradiating the entire gland.

The MINDACT study is managed and sponsored by the EORTC in collaboration with the Breast International Group (BIG) and included 6,693 women with early stage breast cancer (lymph node negative or 1 - 3 lymph node positive).

While women with early stage breast cancer often are cured of their disease, they live with surgical consequences throughout survivorship.

For the study, UNC Lineberger researchers surveyed 1,141 men who were diagnosed with early - stage prostate cancer between January 2011 and June 2013.

«Adding these two biomarkers provided statistically significant improvement for all early stage cancer versus healthy controls as well as other subcohorts when used with the current gold standard biomarker, CA 19 - 9,» said Ann Killary, Ph.D., professor of Translational Molecular Pathology.

Adding two blood - borne proteins associated with cancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Instcancer cell migration increases the predictive ability of the current biomarker for pancreatic cancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Instcancer to detect early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer InstCancer Center reports in the Journal of the National Cancer InstCancer Institute.

With obesity rates climbing during the past 20 years within the United States and colon cancer being the second - leading killer of men and women in the nation, these facts compelled Fenton and her team to conduct research which could identify the specific biomarkers of obesity and early - stage colon cancer and help in prevention efforts.

Scientific American spoke with geneticist and oncologist Amanda Paulovich, director of the Fred Hutchinson's Early Detection Initiative, about the work she and her team are doing to find biomarkers that can identify cancer in its most formative stages.

Considering the thousands of people diagnosed with these cancers annually, a 1 % increase in early - stage diagnosis could add up to a significant number of new cases and potentially lead to better outcomes.

«Although there is a high risk of progression to decompensated cirrhosis and liver cancer among patients with advanced fibrosis, limiting access to people who have already progressed to late - stage disease as compared to treating earlier to prevent these liver - related complications seems counter-intuitive as a public health strategy.»

This assessment may represent a powerful biomarker to predict cancer progression for men with early - stage prostate cancer.

But the early stage work is promising, he says, because it holds out hope that doctors will soon be able to image breast cancer with several techniques simultaneously, significantly increasing the chances of spotting the disease in its earliest stages.

Dr. Sparano continued: «This is the first prospectively conducted clinical trial evaluating this assay — or any multigene expression assay for that matter — in which patients with early stage breast cancer were uniformly treated based on their assay results.

Among women diagnosed with early - stage breast cancer in California, the percentage undergoing a double mastectomy increased substantially between 1998 and 2011, although this procedure was not associated with a lower risk of death than breast - conserving surgery plus radiation, according to a study in the September 3 issue of JAMA.

The findings provide the highest level of evidence supporting expert - derived clinical practice guidelines which have recommended Oncotype DX in patients with early stage ER - positive breast cancer.

«The compelling results seen in this global study provide unequivocal evidence supporting the clinical utility of Oncotype DX to risk - stratify patients with early stage breast cancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medcancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of MedCancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medicine.

«These findings will give women with early stage breast cancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer greater certainty that anti-estrogen therapy will decrease their risk of recurrence and increase their chance for survival whereas chemotherapy will not,» said breast cancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates Commcancer survivor Mary Lou Smith, JD, MBA, who helped design the study as a leader in the ECOG - ACRIN Cancer Research Advocates CommCancer Research Advocates Committee.

Initial results were announced from the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, a multi-center prospectively conducted trial of more than 10,000 women with early stage breast cancer sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health,cancer sponsored by the National Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health,Cancer Institute (NCI), part of the National Institutes of Health, and led by the ECOG - ACRIN Cancer Research Group (ECOG - ACRIN) with support from Genomic Health,Cancer Research Group (ECOG - ACRIN) with support from Genomic Health, Inc..

In the 1980s, both US - based and international randomized clinical studies found that BCT and mastectomy offered women with early stage breast cancer equal survival benefit.

When factoring in what is now known about breast cancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone - receptor positive disease, according to research from The University of Texas MD Anderson Cancer Ccancer biology and heterogeneity, breast conserving therapy (BCT) may offer a greater survival benefit over mastectomy to women with early stage, hormone - receptor positive disease, according to research from The University of Texas MD Anderson Cancer CCancer Center.

The researchers worked with other collaborators to measure the in situ activity of these two enzymes in patients with early stage lung cancer.

Researchers surveyed 2,362 women newly diagnosed with early stage breast cancer.

A new study finds that more than half of women with early stage breast cancer considered an aggressive type of surgery to remove both breasts.

In early 2004, she was diagnosed with advanced stage breast cancer.

Seven guidelines exclusively deal with early breast cancer, four further guidelines with advanced breast cancer (stage IV).

African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Ccancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer CCancer Center.

With a test to look for elevated levels of miR - 34a, researchers could create an early warning system to catch cancers in their youthful stages when they are much easier to cure.

Appropriate patients with early stage breast cancer should not opt for less than this standard in care if properly educated,» Black continues.

«Patients with inoperable, early - stage lung cancer who receive stereotactic body radiation therapy have 40 % five - year survival rate.»

«With increased access to this potentially life - saving treatment, we can continue to improve outcomes for the growing population of elderly patients fighting early stage cancer.»

«Pancreatic cancer is a disease with a poor prognosis, mainly because of the inability to detect the tumor at an early stage, its high potential for early dissemination, and its relatively poor sensitivity to chemotherapy or radiation therapy,» according to background information in the article.

Oncologists welcome gene expression profiling tests as an added tool in deciding whether women with early - stage breast cancer should have chemotherapy, a new study has found.

Although the research is at an early stage, our findings may have an important impact in the way we treat patients with bowel cancer in the future.»

The new link fits with evidence that males who were exposed to excess estrogen hormones at an early stage of fetal development may face an elevated risk of developing testicular cancer.

Nuclear localization of KLF4 is associated with an aggressive phenotype in early - stage breast cancer

Dogs diagnosed with bone cancer often arrive at the clinic at a very advanced stage of the disease, whereas in humans, bone cancer is usually detected early because people complain about the pain and have it investigated.

FAK inhibitors are being tested on their own in early stage cancer clinical trials, but it will be some years before it is known if combining these drugs with BRAF inhibitors could help patients.